131 related articles for article (PubMed ID: 4439501)
41. Specific active immunotherapy for melanoma.
Seigler HF; Cox E; Mutzner F; Shepherd L; Nicholson E; Shingleton WW
Ann Surg; 1979 Sep; 190(3):366-72. PubMed ID: 485611
[No Abstract] [Full Text] [Related]
42. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule.
Gutterman JU; Mavligit G; McBride C; Frei E; Hersh EM
Natl Cancer Inst Monogr; 1973 Dec; 39():205-12. PubMed ID: 4595319
[No Abstract] [Full Text] [Related]
43. [Immunology of malignant melanoma (author's transl)].
Macher E; Sorg C; Seibert Er
Langenbecks Arch Chir; 1976 Nov; 342():533-8. PubMed ID: 994670
[TBL] [Abstract][Full Text] [Related]
44. [Combined treatment of patients with metastases of skin melanoma using cryotherapy].
Iavorskiĭ VV; Karaseva VV; Tokareva ZI
Vopr Onkol; 1988; 34(7):799-803. PubMed ID: 3420821
[TBL] [Abstract][Full Text] [Related]
45. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
46. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
47. The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.
Lieberman R; Wybran J; Epstein W
Cancer; 1975 Mar; 35(3):756-77. PubMed ID: 234295
[TBL] [Abstract][Full Text] [Related]
48. [Possibilities of an immunotherapy of malignant skin tumors with particular consideration of malignant melanomas (author's transl)].
Schöpf E
Ther Umsch; 1976 Aug; 33(8):538-42. PubMed ID: 1006610
[No Abstract] [Full Text] [Related]
49. Immunotherapy in malignant melanomaa.
Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL
Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
[TBL] [Abstract][Full Text] [Related]
50. Immunotherapy for human malignant melanoma.
Kopf AW
South Med J; 1975 Apr; 68(4):495-503. PubMed ID: 1124416
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant immunotherapy with BCG in stage II malignant melanoma.
Byrne MJ; Van Hazel G; Reynolds PM; Lemish WM; Holman CD
J Surg Oncol; 1983 Jun; 23(2):114-6. PubMed ID: 6343725
[TBL] [Abstract][Full Text] [Related]
52. A Phase II study of autologous irradiated tumor cells plus BCG in patients with metastatic malignant melanoma.
Laucius JF; Bodurtha AJ; Mastrangelo JM; Bellet RE
Cancer; 1977 Nov; 40(5):2091-3. PubMed ID: 336181
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781).
Henz BM; Macher E; Bröcker EB; Suciu S; Steerenberg PA; Jung E; Rümke P
Dermatology; 1996; 193(2):105-9. PubMed ID: 8884144
[TBL] [Abstract][Full Text] [Related]
54. [Treatment of malignant melanoma (author's transl)].
Civatte J; Jourdain JC
MMW Munch Med Wochenschr; 1978 Mar; 120(12):403-6. PubMed ID: 306028
[TBL] [Abstract][Full Text] [Related]
55. Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases.
Mastrangelo MJ; Bellet RE; Berkelhammer J; Clark WH
Cancer; 1975 Oct; 36(4):1305-8. PubMed ID: 1175129
[TBL] [Abstract][Full Text] [Related]
56. Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy.
Hedley DW; McElwain TJ; Currie GA
Eur J Cancer (1965); 1977 Oct; 13(10):1169-73. PubMed ID: 923614
[No Abstract] [Full Text] [Related]
57. Immunotherapy for malignant melanoma with a tumor cell vaccine.
Slingluff CL; Seigler HF
Ann Plast Surg; 1992 Jan; 28(1):104-7. PubMed ID: 1642395
[TBL] [Abstract][Full Text] [Related]
58. [Immunotherapy of malignant melanoma].
Adler A
Harefuah; 1986 Jul; 111(1-2):11-7. PubMed ID: 3781371
[No Abstract] [Full Text] [Related]
59. The immune response in human malignant melanoma.
Mackie RM
Clin Exp Dermatol; 1976 Mar; 1(1):23-8. PubMed ID: 773575
[No Abstract] [Full Text] [Related]
60. [Immunologic aspects of the treatment of melanoma].
Pawlowska EM
Pol Tyg Lek; 1977 Jun; 32(24):939-41. PubMed ID: 882435
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
